Celebrating Innovation Impact: NTU Deeptech Spin-off Making a Difference

Celebrating Innovation Impact:
NTU Deeptech Spin-off Making a Difference

Last month, on World IP Day (26 April), we celebrated how innovations from Nanyang Technological University, Singapore are making real-world impact — far beyond the research lab.

One standout example is a microneedle patch developed jointly by scientists from NTU and the National Skin Centre (Singapore). This breakthrough technology, spun off into the biotech firm RNAscence Biotechnology, has been shown to reduce excessive scarring by up to 80 per cent. It uses RNA-based methods involving messenger molecules that carry genetic information from DNA, and is now helping patients with keloids and other severe scarring conditions.

Did you know? NTU has filed over 500 technology inventions and disclosures, and licensed out more than 125 technologies in the past year alone with support from NTUitive. Over the past five years, more than 550 intellectual properties — including patents — have been licensed out, highlighting NTU’s commitment to driving innovation forward.

 

Photo: (Clockwise from top left) RNAscence Biotech team Dr Yong Yao CHUN, Chief Technical Advisor; Prof Jack WONG, CEO; Diana CHOR, General Manager; Prof Hong Liang TEY, Chief Clinical Advisor; Prof. Timothy TAN, Chief Scientific Advisor and Chief Strategy Advisor